Arbutus Biopharma Corp

XNAS:ABUS 4:00:00 PM EDT

4.58

+0.11 (+2.46%)

7:54:07 PM EDT: $4.57 -0.01 (-0.22%)

Market Cap (Intraday)	877.97M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.27 Million
Adjusted EPS	-$0.03

See more estimates

10-Day MA	$4.43
50-Day MA	$4.23
200-Day MA	$3.54

See more pivots

Arbutus Biopharma Corp Stock, XNAS:ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974

United States of America

Phone: +1.267.469.0914

Number of Employees: 73

http://www.arbutusbio.com

Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.